Weight LossNCT04751916
Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery
A study testing Essential Amino Acid Protein Supplement and Beneprotein® in people with Weight Loss, run by Oregon Health and Science University at 1 site in United States.
Trial summary
Bariatric surgery is an effective treatment for severe obesity but results in loss of muscle mass. The investigators will test the hypothesis that consumption of an Essential Amino Acid-based nutritional formulation will maintain muscle mass while stimulating fat loss after bariatric surgery. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Weight Loss
- What is being tested?
- Essential Amino Acid Protein Supplement and Beneprotein®
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Mar 2021to 28 Feb 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- A determination to proceed with bariatric surgery
- Roux-en-Y gastric bypass or sleeve gastrectomy
- Absence of any exclusion
Who cannot join
- Contraindications to Magnetic Resonance Spectroscopy/Magnetic Resonance Imaging
- greater than 450 pounds (scan table limit)
- Renal Failure requiring dialysis
- Liver disease as indicated by bilirubin >2 or Fibrosis-4 score ≥6
- Cardiac disease such as Left Ventricular Assist Device requirement
- Uncontrolled diabetes as indicated by Hemoglobin A1c >8
Show all 9Show fewer
- Positive pregnancy test (for participants in whom pregnancy is possible)
- Any other exclusion per indication of clinical surgeon
- Refusal to consume study formula
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
Oregon Health and Science University
Portland, Oregon, 97239
Nancy Puzziferri, MD, 503-494-1322, puzzifer@ohsu.edu
Lauren Martin, MS, 5034941488, marlaure@ohsu.edu
About this study
Bariatric surgery is an effective treatment for severe obesity but results in loss of muscle mass. The investigators will test the hypothesis that consumption of an Essential Amino Acid-based nutritional formulation will maintain muscle mass while stimulating fat loss after bariatric surgery.
Read the detailed description
- Objectives Bariatric surgery has become a common treatment for severe obesity, and results in a loss of fat mass. However, muscle mass is also lost following bariatric surgery. It is the investigators' overarching premise that consumption of the Essential Amino Acid-based nutritional formulation following bariatric surgery will preserve muscle mass by stimulating muscle protein synthesis. As a result, the energy utilization associated with the combination of maintained muscle mass and stimulated muscle protein synthesis will counter the decrease in metabolic rate that normally occurs in hypocaloric circumstances. Maintenance of a higher total energy expenditure by Essential Amino Acid consumption will accelerate loss of body fat, as well as accelerate loss of body weight. The investigators further propose that consumption of an Essential Amino Acid-based nutritional formulation will reduce muscle intra-cellular lipid accumulation, which will translate to greater improvements in glucose homeostasis and muscle protein metabolism. The loss of muscle mass in those with obesity undergoing rapid weight loss post-bariatric surgery, is not in itself, a disease or a medical condition. The following aims will test specific hypotheses related to the scientific premise: Aim 1. Supplementation of the usual diet following bariatric surgery with a proprietary Essential Amino Acid-based nutritional formulation twice per day for 6 months will maintain muscle mass and reduce fat mass more than supplementation of the diet with an isonitrogenous amount of whey protein. Muscle mass will be directly measured using a novel tracer-dilution technique using deuterium-labeled creatine. Fat mass and lean body mass will be measured by Dual-energy X-ray absorptiometry. Aim 2. Muscle protein fractional synthetic rate and total muscle protein synthesis (muscle mass x fractional synthetic rate) will decline less from pre-surgery values in participants consuming the Essential Amino Acid-based nutritional formulation as compared to whey protein. Muscle protein fractional synthetic rate will be measured by the novel "virtual biopsy" method, which provides an integrated value over three weeks. Aim 3. The pre-surgery rate of total energy expenditure will be better maintained in participants consuming the Essential Amino Acid-based nutritional formulation as opposed to whey protein. Change in total energy expenditure will be measured over 10-day intervals using the doubly-labeled water technique, before to 6 months following surgery. Aim 4. Six months after bariatric surgery muscle intra-cellular lipid accumulation will be reduced from the pre-surgery value to a greater extent in participants consuming the Essential Amino Acid-based nutritional formulation than whey protein. Muscle intra-cellular lipid accumulation will be measured by means of magnetic resonance spectroscopy and magnetic resonance imaging. The investigators anticipate that a greater reduction in intra-cellular lipid accumulation will be related to greater improvement in insulin sensitivity in terms of glucose homeostasis and also in terms of muscle protein synthesis. Positive results of this study will support the value of the Essential Amino Acid-based nutritional formulation in terms of increasing the rate of fat loss and improving body composition changes following bariatric surgery.
- Background Despite successful weight loss and improvement of comorbidities after bariatric surgery, most patients with severe obesity remain overweight. Patients also experience variation in treatment response. Up to 30% patients experience sub-optimal weight loss or significant weight regain. Amount of weight lost and its maintenance are important because they are what lead to improvement/remission of comorbidities (diabetes, heart disease, etc.), and to decreased mortality from cardiovascular disease or cancer. One of the keys to optimal weight loss from a calorie restricted diet, and subsequent weight-loss maintenance, is losing fat without losing muscle (aka lean body mass). It is decreased energy expenditure from decreased muscle mass after weight loss which contributes significantly to weight regain. Muscle mass is the key driver of energy metabolism favoring the burning of food as fuel rather than its storage as fat. Since muscle provides a reservoir of amino acids to maintain protein synthesis essential for survival, its mass quantity is always at risk under conditions of inadequate dietary intake. Skeletal muscle, under the caloric restriction of weight-loss diets, catabolizes to provide the body's unmet protein needs. It becomes challenging to maintain muscle in conditions of severe calorie restriction such as after bariatric surgery. Protein supplementation has been shown to protect against muscle loss experienced in weight loss, but only if supplementation is sufficient. The standard of care approach to maintain muscle mass during rapid, significant weight loss after bariatric surgery has been dietary whey protein supplementation. After bariatric surgery, protein supplementation is limited by the inability of patients to take in sufficient calories. This can be further hindered by typical perioperative complications which limit intake, such as nausea, vomiting, and early satiety. Therefore, despite standard of care supplementation with whey protein post bariatric surgery, only marginal gains in preventing muscle loss have been made. Essential Amino Acid, the intervention supplement in this study, is a patented formula scientifically shown to be far more anabolic than whey protein in free-living elderly and young healthy adults undergoing bedrest. The Essential Amino Acid supplement stimulates protein synthesis 3-5 times as effectively as whey protein, with negligible non-protein calories. The importance of the role of muscle in weight loss and its maintenance cannot be overemphasized. Muscle, crucial to energy metabolism, is responsible for the majority of total energy expenditure (equivalent to physical activity energy expenditure, resting energy expenditure, and diet induced thermogenesis - calories required to digest food). Both physical activity, and muscle protein synthesis comprise a significant portion of energy expenditure. Through its function in physical activity and protein synthesis, muscle largely determines the caloric expenditure underlying the ability to 'use up' food eaten rather than store it as fat. Obesity, is not just increased body fat, but also increased intramuscular fat. The intramuscular fat associated with obesity impairs the muscle function of providing normal glucose homeostasis. Fortunately, when fat stored in muscle decreases, insulin sensitivity improves. Also impaired under conditions of increased intramuscular fat, is the function of providing amino acids to maintain essential protein synthesis. Impaired muscle mitochondria-stimulated protein synthesis potentially decreases resting energy expenditure, and diet induced thermogenesis. Adequate protein supplementation can counter muscle mitochondrial protein synthesis impairment, and in theory, lead to decreased intramuscular fat improving both energy expenditure and insulin sensitivity.
- Study Design
This is a double-blinded randomized clinical trial in which the responses to consumption of one of two different dietary supplements following bariatric surgery will be determined. A variety of factors related to body composition and muscle metabolism will be quantified in participants with obesity before and approximately 6 months after bariatric surgery. This interval of time was selected because additional body weight changes are generally relatively small 6 months after surgery; most of the weight loss occurs in the first 6 months. Participants will be assigned randomly by computer to receive either an Essential Amino Acid based nutritional supplement (intervention) or a commercially-available whey protein supplement (Beneprotein®).
- Conditions
- Weight Loss
- Being tested
- Essential Amino Acid Protein Supplement, Beneprotein®
- Keywords
- bariatric surgery, muscle synthesis, weight loss, essential amino acids, protein supplementation, total energy expenditure
- Medical subject headings
- Weight Loss
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Essential Amino Acid Protein SupplementDietary supplement
Proprietary essential amino acid protein supplement
Beneprotein®Dietary supplement
Whey protein supplement
| Study group | Role | What they receive |
|---|---|---|
| Proprietary Essential Amino Acid Protein Supplement | Experimental | Essential amino acid protein supplement; 15 grams (one packet) dissolved in 8 ounces of water twice daily for 6 months. Receives: Dietary Supplement: Essential Amino Acid Protein Supplement |
| Commercially-available whey protein supplement - Beneprotein® | Active comparator | Beneprotein® whey protein supplement; 15 grams (one packet) dissolved in 8 ounces of water twice daily for 6 months. Receives: Dietary Supplement: Beneprotein® |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lean body mass
Lean body mass in kilograms
Measured: Baseline (before bariatric surgery)
Lean body mass
Lean body mass in kilograms
Measured: 6 months after bariatric surgery
Total energy expenditure
Total energy expenditure in kilocalories per day
Measured: Baseline (before bariatric surgery)
Total energy expenditure
Total energy expenditure in kilocalories per day
Measured: 6 months after bariatric surgery
Muscle mass
Muscle mass in kilograms
Measured: Baseline (before bariatric surgery)
Muscle mass
Muscle mass in kilograms
Measured: 6 months after bariatric surgery
Secondary outcomes (30)
Liver fat mass
Liver fat mass in kilograms
Measured: Baseline (before bariatric surgery)
Liver fat mass
Liver fat mass in kilograms
Measured: 6 months after bariatric surgery
Visceral fat mass
Visceral fat mass in kilograms
Measured: Baseline (before bariatric surgery)
Visceral fat mass
Visceral fat mass in kilograms
Measured: 6 months after bariatric surgery
Subcutaneous fat mass
Subcutaneous fat mass in kilograms
Measured: Baseline (before bariatric surgery)
Subcutaneous fat mass
Subcutaneous fat mass in kilograms
Measured: 6 months after bariatric surgery
Whole body fat mass
Whole body fat mass in kilograms
Measured: Baseline (before bariatric surgery)
Whole body fat mass
Whole body fat mass in kilograms
Measured: 6 months after bariatric surgery
Weight
Weight in kilograms
Measured: Baseline (before bariatric surgery)
Weight
Weight in kilograms
Measured: 6 months after bariatric surgery
Resting energy expenditure
Resting energy expenditure in kilocalories per day
Measured: Baseline (before bariatric surgery)
Resting energy expenditure
Resting energy expenditure in kilocalories per day
Measured: 6 months after bariatric surgery
Diet induced thermogenesis
Percent kilocalories expended to digest a kilocalorie of protein
Measured: Baseline (before bariatric surgery)
Diet induced thermogenesis
Percent kilocalories expended to digest a kilocalorie of protein
Measured: 6 months after bariatric surgery
Glucose
Blood plasma glucose in milligrams per deciliter
Measured: Baseline (before bariatric surgery)
Glucose
Blood plasma glucose in milligrams per deciliter
Measured: 6 months after bariatric surgery
Insulin
Blood serum insulin in micro-international units per milliliter
Measured: Baseline (before bariatric surgery)
Insulin
Blood serum insulin in micro-international units per milliliter
Measured: 6 months after bariatric surgery
Essential amino acids
Blood plasma essential amino acids in micromoles per liter
Measured: Baseline (before bariatric surgery)
Essential amino acids
Blood plasma essential amino acids in micromoles per liter
Measured: 6 months after bariatric surgery
Dietary intake (Objective)
Dietary record of intake in kilocalories per day for 3 days
Measured: Baseline (before bariatric surgery)
Dietary intake (Objective)
Dietary record of intake in kilocalories per day for 3 days
Measured: 6 months after bariatric surgery
Physical activity (Objective)
Physical activity by accelerometer kilocalories per day for 7 days
Measured: Baseline (before bariatric surgery)
Physical activity (Objective)
Physical activity by accelerometer kilocalories per day for 7 days
Measured: 6 months after bariatric surgery
Percent muscle fat
Muscle fat in kilogram percent
Measured: Baseline (before bariatric surgery)
Percent muscle fat
Muscle fat in kilogram percent
Measured: 6 months after bariatric surgery
Muscle protein synthetic rate
Muscle protein synthetic rate in kilograms per day
Measured: Baseline (before bariatric surgery)
Muscle protein synthetic rate
Muscle protein synthetic rate in kilograms per day
Measured: 6 months after bariatric surgery
Muscle protein fractional synthetic rate
Muscle protein fractional synthetic rate in kilogram percent per day
Measured: Baseline (before bariatric surgery)
Muscle protein fractional synthetic rate
Muscle protein fractional synthetic rate in kilogram percent per day
Measured: 6 months after bariatric surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2021
- Study start9 Mar 2021
- Primary completion28 Feb 2024 (estimated)
- Study completion28 Feb 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (24)Papers the sponsor has linked to this study.
- Other trials for Weight LossStudies of the same condition, open and under way.
- More trials run by Oregon Health and Science UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- double-blinded randomized clinical trial
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Oregon Health and Science University
- Sponsor type
- University, hospital or other
- Collaborators
- The Amino Company, LLC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Responsible party
- Principal investigator, Nancy Puzziferri, Oregon Health and Science University
- Investigators
- Nancy Puzziferri, MD MSCS, Principal investigator, Oregon Health and Science University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04751916
- Sponsor's protocol ID
- 1R44DK125151-00021210
- Other IDs
- 1R44DK125151
- Status last verified
- Mar 2023
- First submitted
- 2 Feb 2021
- Last updated
- 4 Apr 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data (and data dictionaries) for this study will be available once fully collected and de-identified. The study protocol, statistical analysis plan, informed consent form, and clinical study reports will also be available. Data will be available immediately following publication without an access end date. Anyone may access the data, for any purpose. Data will be available indefinitely at a link to be provided at study completion.
Publications
Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, Singh A, Spaniolas K, Thirlby R, Wolfe BM, Yanovski SZ. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018 May 1;153(5):427-434. doi: 10.1001/jamasurg.2017.5025.
PubMed 29214306Lent MR, Hu Y, Benotti PN, Petrick AT, Wood GC, Still CD, Kirchner HL. Demographic, clinical, and behavioral determinants of 7-year weight change trajectories in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2018 Nov;14(11):1680-1685. doi: 10.1016/j.soard.2018.07.023. Epub 2018 Jul 30.
PubMed 30166262King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes. JAMA. 2018 Oct 16;320(15):1560-1569. doi: 10.1001/jama.2018.14433.
PubMed 30326125Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lonroth H, Narbro K, Naslund I, Olbers T, Svensson PA, Carlsson LM. Bariatric surgery and long-term cardiovascular events. JAMA. 2012 Jan 4;307(1):56-65. doi: 10.1001/jama.2011.1914.
PubMed 22215166Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009 Apr;17(4):796-802. doi: 10.1038/oby.2008.610. Epub 2009 Jan 15.
PubMed 19148123Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R581-600. doi: 10.1152/ajpregu.00755.2010. Epub 2011 Jun 15.
PubMed 21677272Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995 Mar 9;332(10):621-8. doi: 10.1056/NEJM199503093321001.
PubMed 7632212Felig P, Owen OE, Wahren J, Cahill GF Jr. Amino acid metabolism during prolonged starvation. J Clin Invest. 1969 Mar;48(3):584-94. doi: 10.1172/JCI106017.
PubMed 5773094Cahill GF Jr. Starvation in man. N Engl J Med. 1970 Mar 19;282(12):668-75. doi: 10.1056/NEJM197003192821209. No abstract available.
PubMed 4915800Weijs PJM, Wolfe RR. Exploration of the protein requirement during weight loss in obese older adults. Clin Nutr. 2016 Apr;35(2):394-398. doi: 10.1016/j.clnu.2015.02.016. Epub 2015 Mar 6.
PubMed 25788405Hector AJ, McGlory C, Damas F, Mazara N, Baker SK, Phillips SM. Pronounced energy restriction with elevated protein intake results in no change in proteolysis and reductions in skeletal muscle protein synthesis that are mitigated by resistance exercise. FASEB J. 2018 Jan;32(1):265-275. doi: 10.1096/fj.201700158RR. Epub 2017 Sep 12.
PubMed 28899879Schollenberger AE, Karschin J, Meile T, Kuper MA, Konigsrainer A, Bischoff SC. Impact of protein supplementation after bariatric surgery: A randomized controlled double-blind pilot study. Nutrition. 2016 Feb;32(2):186-92. doi: 10.1016/j.nut.2015.08.005. Epub 2015 Sep 1.
PubMed 26691769Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, Casperson SL, Jiang J, Chinkes DL, Urban RJ. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab. 2009 May;94(5):1630-7. doi: 10.1210/jc.2008-1564. Epub 2009 Feb 10.
PubMed 19208731Borsheim E, Bui QU, Tissier S, Kobayashi H, Ferrando AA, Wolfe RR. Effect of amino acid supplementation on muscle mass, strength and physical function in elderly. Clin Nutr. 2008 Apr;27(2):189-95. doi: 10.1016/j.clnu.2008.01.001. Epub 2008 Mar 4.
PubMed 18294740Paddon-Jones D, Sheffield-Moore M, Urban RJ, Sanford AP, Aarsland A, Wolfe RR, Ferrando AA; New Collective Author. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab. 2004 Sep;89(9):4351-8. doi: 10.1210/jc.2003-032159.
PubMed 15356032
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery
- ClinicalTrials.gov ID
- NCT04751916
- Acronym / sponsor ID
- 1R44DK125151-00021210
- Conditions
- Weight Loss
- Keywords
- bariatric surgery, muscle synthesis, weight loss, essential amino acids, protein supplementation, total energy expenditure
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Oregon Health and Science UniversityUniversity, hospital or other
- Collaborators
- The Amino Company, LLC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study start
- 9 Mar 2021 (actual)
- Primary completion
- 28 Feb 2024 (estimated)
- Study completion
- 28 Feb 2024 (estimated)
- First posted
- 12 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Bariatric surgery is an effective treatment for severe obesity but results in loss of muscle mass. The investigators will test the hypothesis that consumption of an Essential Amino Acid-based nutritional formulation will maintain muscle mass while stimulating fat loss after bariatric surgery.
Detailed description
- Objectives Bariatric surgery has become a common treatment for severe obesity, and results in a loss of fat mass. However, muscle mass is also lost following bariatric surgery. It is the investigators' overarching premise that consumption of the Essential Amino Acid-based nutritional formulation following bariatric surgery will preserve muscle mass by stimulating muscle protein synthesis. As a result, the energy utilization associated with the combination of maintained muscle mass and stimulated muscle protein synthesis will counter the decrease in metabolic rate that normally occurs in hypocaloric circumstances. Maintenance of a higher total energy expenditure by Essential Amino Acid consumption will accelerate loss of body fat, as well as accelerate loss of body weight. The investigators further propose that consumption of an Essential Amino Acid-based nutritional formulation will reduce muscle intra-cellular lipid accumulation, which will translate to greater improvements in glucose homeostasis and muscle protein metabolism. The loss of muscle mass in those with obesity undergoing rapid weight loss post-bariatric surgery, is not in itself, a disease or a medical condition. The following aims will test specific hypotheses related to the scientific premise: Aim 1. Supplementation of the usual diet following bariatric surgery with a proprietary Essential Amino Acid-based nutritional formulation twice per day for 6 months will maintain muscle mass and reduce fat mass more than supplementation of the diet with an isonitrogenous amount of whey protein. Muscle mass will be directly measured using a novel tracer-dilution technique using deuterium-labeled creatine. Fat mass and lean body mass will be measured by Dual-energy X-ray absorptiometry. Aim 2. Muscle protein fractional synthetic rate and total muscle protein synthesis (muscle mass x fractional synthetic rate) will decline less from pre-surgery values in participants consuming the Essential Amino Acid-based nutritional formulation as compared to whey protein. Muscle protein fractional synthetic rate will be measured by the novel "virtual biopsy" method, which provides an integrated value over three weeks. Aim 3. The pre-surgery rate of total energy expenditure will be better maintained in participants consuming the Essential Amino Acid-based nutritional formulation as opposed to whey protein. Change in total energy expenditure will be measured over 10-day intervals using the doubly-labeled water technique, before to 6 months following surgery. Aim 4. Six months after bariatric surgery muscle intra-cellular lipid accumulation will be reduced from the pre-surgery value to a greater extent in participants consuming the Essential Amino Acid-based nutritional formulation than whey protein. Muscle intra-cellular lipid accumulation will be measured by means of magnetic resonance spectroscopy and magnetic resonance imaging. The investigators anticipate that a greater reduction in intra-cellular lipid accumulation will be related to greater improvement in insulin sensitivity in terms of glucose homeostasis and also in terms of muscle protein synthesis. Positive results of this study will support the value of the Essential Amino Acid-based nutritional formulation in terms of increasing the rate of fat loss and improving body composition changes following bariatric surgery.
- Background Despite successful weight loss and improvement of comorbidities after bariatric surgery, most patients with severe obesity remain overweight. Patients also experience variation in treatment response. Up to 30% patients experience sub-optimal weight loss or significant weight regain. Amount of weight lost and its maintenance are important because they are what lead to improvement/remission of comorbidities (diabetes, heart disease, etc.), and to decreased mortality from cardiovascular disease or cancer. One of the keys to optimal weight loss from a calorie restricted diet, and subsequent weight-loss maintenance, is losing fat without losing muscle (aka lean body mass). It is decreased energy expenditure from decreased muscle mass after weight loss which contributes significantly to weight regain. Muscle mass is the key driver of energy metabolism favoring the burning of food as fuel rather than its storage as fat. Since muscle provides a reservoir of amino acids to maintain protein synthesis essential for survival, its mass quantity is always at risk under conditions of inadequate dietary intake. Skeletal muscle, under the caloric restriction of weight-loss diets, catabolizes to provide the body's unmet protein needs. It becomes challenging to maintain muscle in conditions of severe calorie restriction such as after bariatric surgery. Protein supplementation has been shown to protect against muscle loss experienced in weight loss, but only if supplementation is sufficient. The standard of care approach to maintain muscle mass during rapid, significant weight loss after bariatric surgery has been dietary whey protein supplementation. After bariatric surgery, protein supplementation is limited by the inability of patients to take in sufficient calories. This can be further hindered by typical perioperative complications which limit intake, such as nausea, vomiting, and early satiety. Therefore, despite standard of care supplementation with whey protein post bariatric surgery, only marginal gains in preventing muscle loss have been made. Essential Amino Acid, the intervention supplement in this study, is a patented formula scientifically shown to be far more anabolic than whey protein in free-living elderly and young healthy adults undergoing bedrest. The Essential Amino Acid supplement stimulates protein synthesis 3-5 times as effectively as whey protein, with negligible non-protein calories. The importance of the role of muscle in weight loss and its maintenance cannot be overemphasized. Muscle, crucial to energy metabolism, is responsible for the majority of total energy expenditure (equivalent to physical activity energy expenditure, resting energy expenditure, and diet induced thermogenesis - calories required to digest food). Both physical activity, and muscle protein synthesis comprise a significant portion of energy expenditure. Through its function in physical activity and protein synthesis, muscle largely determines the caloric expenditure underlying the ability to 'use up' food eaten rather than store it as fat. Obesity, is not just increased body fat, but also increased intramuscular fat. The intramuscular fat associated with obesity impairs the muscle function of providing normal glucose homeostasis. Fortunately, when fat stored in muscle decreases, insulin sensitivity improves. Also impaired under conditions of increased intramuscular fat, is the function of providing amino acids to maintain essential protein synthesis. Impaired muscle mitochondria-stimulated protein synthesis potentially decreases resting energy expenditure, and diet induced thermogenesis. Adequate protein supplementation can counter muscle mitochondrial protein synthesis impairment, and in theory, lead to decreased intramuscular fat improving both energy expenditure and insulin sensitivity.
- Study Design
This is a double-blinded randomized clinical trial in which the responses to consumption of one of two different dietary supplements following bariatric surgery will be determined. A variety of factors related to body composition and muscle metabolism will be quantified in participants with obesity before and approximately 6 months after bariatric surgery. This interval of time was selected because additional body weight changes are generally relatively small 6 months after surgery; most of the weight loss occurs in the first 6 months. Participants will be assigned randomly by computer to receive either an Essential Amino Acid based nutritional supplement (intervention) or a commercially-available whey protein supplement (Beneprotein®).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- double-blinded randomized clinical trial
| Arm | Type | Receives |
|---|---|---|
| Proprietary Essential Amino Acid Protein Supplement | Experimental | Dietary Supplement: Essential Amino Acid Protein SupplementEssential amino acid protein supplement; 15 grams (one packet) dissolved in 8 ounces of water twice daily for 6 months. |
| Commercially-available whey protein supplement - Beneprotein® | Active comparator | Dietary Supplement: Beneprotein®Beneprotein® whey protein supplement; 15 grams (one packet) dissolved in 8 ounces of water twice daily for 6 months. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- A determination to proceed with bariatric surgery
- Roux-en-Y gastric bypass or sleeve gastrectomy
- Absence of any exclusion
Key exclusion criteria (9 listed)
- Contraindications to Magnetic Resonance Spectroscopy/Magnetic Resonance Imaging
- greater than 450 pounds (scan table limit)
- Renal Failure requiring dialysis
- Liver disease as indicated by bilirubin >2 or Fibrosis-4 score ≥6
- Cardiac disease such as Left Ventricular Assist Device requirement
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Essential Amino Acid Protein SupplementProprietary essential amino acid protein supplement | Dietary supplement | Proprietary Essential Amino Acid Protein Supplement |
| Beneprotein®Whey protein supplement | Dietary supplement | Commercially-available whey protein supplement - Beneprotein® |
Primary outcome
Lean body mass
Time frame: Baseline (before bariatric surgery)
Lean body mass in kilograms
Lean body mass
Time frame: 6 months after bariatric surgery
Lean body mass in kilograms
Total energy expenditure
Time frame: Baseline (before bariatric surgery)
Total energy expenditure in kilocalories per day
Total energy expenditure
Time frame: 6 months after bariatric surgery
Total energy expenditure in kilocalories per day
Muscle mass
Time frame: Baseline (before bariatric surgery)
Muscle mass in kilograms
Muscle mass
Time frame: 6 months after bariatric surgery
Muscle mass in kilograms
30 secondary outcomes
Liver fat mass
Time frame: Baseline (before bariatric surgery)
Liver fat mass
Time frame: 6 months after bariatric surgery
Visceral fat mass
Time frame: Baseline (before bariatric surgery)
Visceral fat mass
Time frame: 6 months after bariatric surgery
Subcutaneous fat mass
Time frame: Baseline (before bariatric surgery)
Subcutaneous fat mass
Time frame: 6 months after bariatric surgery
Whole body fat mass
Time frame: Baseline (before bariatric surgery)
Whole body fat mass
Time frame: 6 months after bariatric surgery
Weight
Time frame: Baseline (before bariatric surgery)
Weight
Time frame: 6 months after bariatric surgery
Resting energy expenditure
Time frame: Baseline (before bariatric surgery)
Resting energy expenditure
Time frame: 6 months after bariatric surgery
Diet induced thermogenesis
Time frame: Baseline (before bariatric surgery)
Diet induced thermogenesis
Time frame: 6 months after bariatric surgery
Glucose
Time frame: Baseline (before bariatric surgery)
Glucose
Time frame: 6 months after bariatric surgery
Insulin
Time frame: Baseline (before bariatric surgery)
Insulin
Time frame: 6 months after bariatric surgery
Essential amino acids
Time frame: Baseline (before bariatric surgery)
Essential amino acids
Time frame: 6 months after bariatric surgery
Dietary intake (Objective)
Time frame: Baseline (before bariatric surgery)
Dietary intake (Objective)
Time frame: 6 months after bariatric surgery
Physical activity (Objective)
Time frame: Baseline (before bariatric surgery)
Physical activity (Objective)
Time frame: 6 months after bariatric surgery
Percent muscle fat
Time frame: Baseline (before bariatric surgery)
Percent muscle fat
Time frame: 6 months after bariatric surgery
Muscle protein synthetic rate
Time frame: Baseline (before bariatric surgery)
Muscle protein synthetic rate
Time frame: 6 months after bariatric surgery
Muscle protein fractional synthetic rate
Time frame: Baseline (before bariatric surgery)
Muscle protein fractional synthetic rate
Time frame: 6 months after bariatric surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2023.
- Background: PubMed 29214306Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, Singh A, Spaniolas K, Thirlby R, Wolfe BM, Yanovski SZ. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018 May 1;153(5):427-434. doi: 10.1001/jamasurg.2017.5025.
- Background: PubMed 30166262Lent MR, Hu Y, Benotti PN, Petrick AT, Wood GC, Still CD, Kirchner HL. Demographic, clinical, and behavioral determinants of 7-year weight change trajectories in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2018 Nov;14(11):1680-1685. doi: 10.1016/j.soard.2018.07.023. Epub 2018 Jul 30.
- Background: PubMed 30326125King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes. JAMA. 2018 Oct 16;320(15):1560-1569. doi: 10.1001/jama.2018.14433.
- Background: PubMed 22215166Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lonroth H, Narbro K, Naslund I, Olbers T, Svensson PA, Carlsson LM. Bariatric surgery and long-term cardiovascular events. JAMA. 2012 Jan 4;307(1):56-65. doi: 10.1001/jama.2011.1914.
- Background: PubMed 19148123Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009 Apr;17(4):796-802. doi: 10.1038/oby.2008.610. Epub 2009 Jan 15.
- Background: PubMed 21677272Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R581-600. doi: 10.1152/ajpregu.00755.2010. Epub 2011 Jun 15.
- Background: PubMed 7632212Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995 Mar 9;332(10):621-8. doi: 10.1056/NEJM199503093321001.
- Background: PubMed 5773094Felig P, Owen OE, Wahren J, Cahill GF Jr. Amino acid metabolism during prolonged starvation. J Clin Invest. 1969 Mar;48(3):584-94. doi: 10.1172/JCI106017.
- Background: PubMed 4915800Cahill GF Jr. Starvation in man. N Engl J Med. 1970 Mar 19;282(12):668-75. doi: 10.1056/NEJM197003192821209. No abstract available.
- Background: PubMed 25788405Weijs PJM, Wolfe RR. Exploration of the protein requirement during weight loss in obese older adults. Clin Nutr. 2016 Apr;35(2):394-398. doi: 10.1016/j.clnu.2015.02.016. Epub 2015 Mar 6.
- Background: PubMed 28899879Hector AJ, McGlory C, Damas F, Mazara N, Baker SK, Phillips SM. Pronounced energy restriction with elevated protein intake results in no change in proteolysis and reductions in skeletal muscle protein synthesis that are mitigated by resistance exercise. FASEB J. 2018 Jan;32(1):265-275. doi: 10.1096/fj.201700158RR. Epub 2017 Sep 12.
- Background: PubMed 26691769Schollenberger AE, Karschin J, Meile T, Kuper MA, Konigsrainer A, Bischoff SC. Impact of protein supplementation after bariatric surgery: A randomized controlled double-blind pilot study. Nutrition. 2016 Feb;32(2):186-92. doi: 10.1016/j.nut.2015.08.005. Epub 2015 Sep 1.
- Individual participant dataSharing planned: Yes. Individual participant data (and data dictionaries) for this study will be available once fully collected and de-identified. The study protocol, statistical analysis plan, informed consent form, and clinical study reports will also be available. Data will be available immediately following publication without an access end date. Anyone may access the data, for any purpose. Data will be available indefinitely at a link to be provided at study completion.
Related trials for Weight Loss
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
Physical Inactivity, Overweight and Obesity
RecruitingPhase 1/2
Phase 1/2 Study of DS010 in Advanced Cancer Patients With Cachexia
Cancer, Cachexia
Active, not recruitingPhase 3
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Diabetes Mellitus, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nancy Puzziferri, MD MSCS principal investigator
Oregon Health and Science University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Essential Amino Acid Protein Supplement and Beneprotein® in people with Weight Loss, run by Oregon Health and Science University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lauren P Martin, MS RD LD ((971)288-8487, marlaure@ohsu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lean body mass (time frame: Baseline (before bariatric surgery)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04751916, which also lists 24 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2023.